Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BGS649 in Obese Hypogonadotropic Hypogonadism
NCT01200862Phase 2Terminated
- Sponsor
- Mereo BioPharma
- Start
- Aug 2010
- Primary completion
- Aug 2012
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of leflutrozole in hypogonadotropic hypogonadism (HH), sponsored by Mereo BioPharma. Started Aug 2010; status: terminated.
02
Drugs
leflutrozole
03
Conditions
hypogonadotropic hypogonadism (HH)
Beyond the preview
Go deeper on NCT01200862.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01200862.